| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligonucleotide Array Sequence Analysis | 20 | 2014 | 320 | 3.160 |
Why?
|
| Flatfishes | 5 | 2014 | 5 | 1.440 |
Why?
|
| Endocrine Disruptors | 6 | 2014 | 31 | 1.370 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 208 | 1.180 |
Why?
|
| Pharmacogenetics | 4 | 2010 | 47 | 0.980 |
Why?
|
| Gene Expression | 11 | 2014 | 770 | 0.870 |
Why?
|
| Water Pollutants, Chemical | 8 | 2014 | 328 | 0.690 |
Why?
|
| Gene Expression Profiling | 17 | 2014 | 498 | 0.640 |
Why?
|
| Gene Expression Regulation | 10 | 2014 | 1293 | 0.620 |
Why?
|
| Liver | 8 | 2014 | 1118 | 0.580 |
Why?
|
| Genomics | 2 | 2008 | 168 | 0.510 |
Why?
|
| Fish Proteins | 3 | 2014 | 20 | 0.500 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 68 | 0.460 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 77 | 0.460 |
Why?
|
| DNA, Complementary | 6 | 2005 | 251 | 0.450 |
Why?
|
| Animals, Newborn | 2 | 2014 | 396 | 0.450 |
Why?
|
| Retinal Diseases | 1 | 2013 | 40 | 0.440 |
Why?
|
| Peptide Library | 1 | 2012 | 16 | 0.430 |
Why?
|
| Stress, Physiological | 2 | 2014 | 215 | 0.420 |
Why?
|
| Animals | 39 | 2014 | 20881 | 0.420 |
Why?
|
| Retinal Degeneration | 1 | 2013 | 75 | 0.420 |
Why?
|
| Antigens, Neoplasm | 2 | 2010 | 132 | 0.410 |
Why?
|
| Antibodies | 2 | 2012 | 241 | 0.410 |
Why?
|
| Microarray Analysis | 3 | 2013 | 63 | 0.410 |
Why?
|
| Environmental Exposure | 1 | 2014 | 269 | 0.400 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 493 | 0.390 |
Why?
|
| Receptors, Immunologic | 4 | 2008 | 72 | 0.370 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 442 | 0.360 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2010 | 2 | 0.360 |
Why?
|
| Technology, Pharmaceutical | 1 | 2010 | 8 | 0.360 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 29 | 0.350 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 11 | 0.330 |
Why?
|
| Base Sequence | 8 | 2014 | 1015 | 0.320 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.320 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 137 | 0.290 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2008 | 47 | 0.290 |
Why?
|
| Biomedical Technology | 1 | 2006 | 14 | 0.280 |
Why?
|
| Genetic Testing | 1 | 2008 | 159 | 0.280 |
Why?
|
| Biomarkers | 8 | 2014 | 1593 | 0.280 |
Why?
|
| Zebrafish | 3 | 2014 | 187 | 0.280 |
Why?
|
| HIV Infections | 1 | 2013 | 791 | 0.260 |
Why?
|
| Cell Differentiation | 4 | 2014 | 1034 | 0.250 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 562 | 0.250 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1447 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2014 | 328 | 0.250 |
Why?
|
| Proteome | 2 | 2002 | 87 | 0.250 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 283 | 0.240 |
Why?
|
| Mutation | 3 | 2009 | 1213 | 0.240 |
Why?
|
| Drug Design | 1 | 2005 | 107 | 0.240 |
Why?
|
| Receptors, Prostaglandin | 3 | 2008 | 74 | 0.240 |
Why?
|
| Hybridization, Genetic | 1 | 2004 | 9 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1997 | 411 | 0.240 |
Why?
|
| Protein Array Analysis | 2 | 2011 | 32 | 0.230 |
Why?
|
| Computational Biology | 2 | 2005 | 190 | 0.230 |
Why?
|
| Patents as Topic | 1 | 2003 | 4 | 0.230 |
Why?
|
| Macrophages | 4 | 2011 | 647 | 0.230 |
Why?
|
| Mitochondria | 1 | 2008 | 643 | 0.230 |
Why?
|
| RNA, Messenger | 7 | 2014 | 1664 | 0.220 |
Why?
|
| Models, Animal | 3 | 2014 | 252 | 0.220 |
Why?
|
| Environmental Monitoring | 3 | 2013 | 180 | 0.220 |
Why?
|
| Sea Bream | 2 | 2014 | 2 | 0.220 |
Why?
|
| Biomedical Research | 1 | 2006 | 310 | 0.220 |
Why?
|
| Humans | 32 | 2014 | 68618 | 0.210 |
Why?
|
| Vitellogenins | 4 | 2014 | 5 | 0.200 |
Why?
|
| Immunity, Innate | 3 | 2011 | 156 | 0.200 |
Why?
|
| Phenols | 2 | 2014 | 73 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2014 | 268 | 0.190 |
Why?
|
| California | 2 | 2013 | 99 | 0.190 |
Why?
|
| Mice | 17 | 2014 | 8474 | 0.180 |
Why?
|
| Phenotype | 4 | 2014 | 947 | 0.180 |
Why?
|
| Amino Acid Sequence | 8 | 2014 | 1083 | 0.170 |
Why?
|
| Th2 Cells | 2 | 2008 | 48 | 0.160 |
Why?
|
| Genotype | 3 | 2011 | 786 | 0.150 |
Why?
|
| Drosophila | 2 | 2013 | 37 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 710 | 0.150 |
Why?
|
| Reproduction | 2 | 2014 | 48 | 0.140 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 49 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 615 | 0.140 |
Why?
|
| Brain | 3 | 2011 | 2176 | 0.130 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 1996 | 44 | 0.130 |
Why?
|
| Male | 12 | 2014 | 37321 | 0.130 |
Why?
|
| Oncogenes | 1 | 1996 | 71 | 0.130 |
Why?
|
| Th1 Cells | 1 | 1996 | 101 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2014 | 682 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 334 | 0.130 |
Why?
|
| Genome | 2 | 2013 | 54 | 0.130 |
Why?
|
| Ecotoxicology | 2 | 2011 | 4 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2011 | 114 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 492 | 0.120 |
Why?
|
| Estradiol | 3 | 2014 | 176 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 700 | 0.120 |
Why?
|
| Salmon | 1 | 1994 | 9 | 0.120 |
Why?
|
| Female | 14 | 2014 | 38074 | 0.120 |
Why?
|
| Electron Transport Complex IV | 1 | 1994 | 33 | 0.120 |
Why?
|
| Fish Diseases | 1 | 2014 | 7 | 0.120 |
Why?
|
| DNA Primers | 3 | 2012 | 302 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 57 | 0.120 |
Why?
|
| Tricuspid Valve | 1 | 2014 | 42 | 0.120 |
Why?
|
| Food Contamination | 1 | 2014 | 56 | 0.120 |
Why?
|
| Geologic Sediments | 2 | 2011 | 75 | 0.120 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 10 | 0.120 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2014 | 30 | 0.120 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 39 | 0.120 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 62 | 0.120 |
Why?
|
| Cell Adhesion | 2 | 2013 | 324 | 0.120 |
Why?
|
| Zona Pellucida | 1 | 2013 | 5 | 0.110 |
Why?
|
| Color Vision Defects | 1 | 2013 | 3 | 0.110 |
Why?
|
| Xenobiotics | 1 | 2013 | 17 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2013 | 1174 | 0.110 |
Why?
|
| Hormones | 1 | 2013 | 42 | 0.110 |
Why?
|
| Fluorescein Angiography | 1 | 2013 | 57 | 0.110 |
Why?
|
| Serine Proteases | 1 | 2013 | 1 | 0.110 |
Why?
|
| Wound Healing | 2 | 2013 | 260 | 0.110 |
Why?
|
| Integrin beta1 | 1 | 2013 | 48 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2014 | 246 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 54 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 114 | 0.110 |
Why?
|
| Waste Disposal, Fluid | 1 | 2013 | 55 | 0.110 |
Why?
|
| Pregnancy | 3 | 2014 | 2334 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2014 | 123 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 41 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1994 | 282 | 0.110 |
Why?
|
| Proteins | 1 | 1996 | 474 | 0.110 |
Why?
|
| Cell Division | 2 | 2014 | 541 | 0.110 |
Why?
|
| Flounder | 1 | 2012 | 2 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2013 | 219 | 0.110 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2013 | 74 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 94 | 0.110 |
Why?
|
| Endocrine System | 1 | 2012 | 11 | 0.110 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2014 | 131 | 0.110 |
Why?
|
| Transcriptome | 1 | 2014 | 164 | 0.110 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 166 | 0.100 |
Why?
|
| Calcinosis | 1 | 2014 | 241 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 218 | 0.100 |
Why?
|
| Visual Perception | 1 | 2013 | 124 | 0.100 |
Why?
|
| Aortic Valve | 1 | 2014 | 249 | 0.100 |
Why?
|
| Prostaglandin Antagonists | 2 | 2008 | 11 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2013 | 308 | 0.100 |
Why?
|
| Hydroxyprogesterones | 1 | 2012 | 6 | 0.100 |
Why?
|
| Regeneration | 1 | 2013 | 105 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 231 | 0.100 |
Why?
|
| Probiotics | 1 | 2012 | 14 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2008 | 201 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 177 | 0.100 |
Why?
|
| Ovarian Follicle | 1 | 2012 | 21 | 0.100 |
Why?
|
| Insulin | 2 | 2013 | 619 | 0.100 |
Why?
|
| Integrin alpha3beta1 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Integrin alpha2beta1 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2077 | 0.100 |
Why?
|
| Soil Pollutants | 1 | 2011 | 42 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 33 | 0.100 |
Why?
|
| Glucagon | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2014 | 2673 | 0.100 |
Why?
|
| Endophenotypes | 1 | 2011 | 2 | 0.100 |
Why?
|
| Oryzias | 1 | 2011 | 7 | 0.100 |
Why?
|
| Pancreatic Ducts | 1 | 2011 | 76 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 75 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 103 | 0.090 |
Why?
|
| S100 Proteins | 1 | 2010 | 42 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2013 | 2689 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2008 | 67 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 1998 | 357 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2010 | 60 | 0.090 |
Why?
|
| Inflammation | 3 | 2011 | 1030 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 53 | 0.090 |
Why?
|
| Cytokines | 3 | 2008 | 866 | 0.090 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 23 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2008 | 447 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2010 | 25 | 0.090 |
Why?
|
| Caenorhabditis elegans | 2 | 2000 | 38 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2010 | 45 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 58 | 0.090 |
Why?
|
| Apoptosis | 1 | 1996 | 1641 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2011 | 206 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 186 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2010 | 107 | 0.080 |
Why?
|
| Critical Pathways | 1 | 2009 | 33 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 371 | 0.080 |
Why?
|
| Leishmania infantum | 1 | 2009 | 1 | 0.080 |
Why?
|
| Antimony | 1 | 2009 | 6 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2083 | 0.080 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Trypanocidal Agents | 1 | 2009 | 11 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2009 | 21 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 244 | 0.080 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2008 | 12 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2011 | 431 | 0.080 |
Why?
|
| Interleukin-1alpha | 1 | 2008 | 5 | 0.080 |
Why?
|
| Diethylnitrosamine | 1 | 2008 | 10 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2008 | 10 | 0.080 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 17 | 0.080 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2008 | 96 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 455 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2011 | 753 | 0.080 |
Why?
|
| Antigens | 1 | 2008 | 90 | 0.080 |
Why?
|
| Carcinogens | 1 | 2008 | 86 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2008 | 76 | 0.080 |
Why?
|
| Crigler-Najjar Syndrome | 1 | 2008 | 1 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 84 | 0.080 |
Why?
|
| Autoantigens | 1 | 2008 | 91 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 694 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 786 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2008 | 38 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 35 | 0.080 |
Why?
|
| Telomerase | 1 | 2008 | 85 | 0.080 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 25 | 0.080 |
Why?
|
| Biotransformation | 1 | 2008 | 69 | 0.080 |
Why?
|
| Rats | 2 | 2014 | 5300 | 0.080 |
Why?
|
| Demography | 1 | 2008 | 279 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2009 | 183 | 0.080 |
Why?
|
| Chemokines, CX3C | 2 | 1998 | 3 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2009 | 138 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 2009 | 157 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 87 | 0.070 |
Why?
|
| Adult | 4 | 2013 | 21403 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2007 | 33 | 0.070 |
Why?
|
| Pneumonia | 1 | 2008 | 110 | 0.070 |
Why?
|
| Chromosome Mapping | 4 | 2010 | 188 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 116 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 301 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 148 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 271 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 164 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 226 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2008 | 101 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2014 | 1692 | 0.070 |
Why?
|
| Chemokines | 2 | 1998 | 119 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 83 | 0.070 |
Why?
|
| Piperidines | 1 | 2007 | 123 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2008 | 205 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 68 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2007 | 85 | 0.070 |
Why?
|
| Dronabinol | 1 | 2007 | 84 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1038 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 329 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 195 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2007 | 190 | 0.070 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 182 | 0.060 |
Why?
|
| Cell Line | 4 | 2010 | 1752 | 0.060 |
Why?
|
| Graft Survival | 1 | 2008 | 465 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 44 | 0.060 |
Why?
|
| RNA, Complementary | 1 | 2005 | 1 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| Neoplasms | 2 | 2014 | 1667 | 0.060 |
Why?
|
| DNA | 1 | 2008 | 597 | 0.060 |
Why?
|
| Cell Death | 3 | 2013 | 329 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 248 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 597 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2007 | 470 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2008 | 718 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 592 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 370 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 532 | 0.060 |
Why?
|
| Middle Aged | 2 | 2013 | 21147 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 1998 | 617 | 0.050 |
Why?
|
| RNA | 1 | 2004 | 171 | 0.050 |
Why?
|
| Testosterone | 2 | 2014 | 96 | 0.050 |
Why?
|
| Microcomputers | 1 | 2002 | 32 | 0.050 |
Why?
|
| Scattering, Radiation | 1 | 2002 | 30 | 0.050 |
Why?
|
| Light | 1 | 2002 | 152 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 282 | 0.050 |
Why?
|
| Ethanol | 1 | 2007 | 893 | 0.050 |
Why?
|
| Hybrid Cells | 2 | 1997 | 18 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1997 | 282 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1753 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 166 | 0.040 |
Why?
|
| Alcoholism | 1 | 2007 | 1109 | 0.040 |
Why?
|
| Prostaglandin D2 | 2 | 2008 | 21 | 0.040 |
Why?
|
| Gene Library | 2 | 1999 | 68 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 163 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 235 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 140 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1998 | 4 | 0.040 |
Why?
|
| Organ Specificity | 2 | 1998 | 167 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1997 | 16 | 0.040 |
Why?
|
| Urodela | 1 | 1997 | 31 | 0.040 |
Why?
|
| Xenopus | 1 | 1997 | 30 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 1996 | 15 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 1997 | 57 | 0.040 |
Why?
|
| Proviruses | 1 | 1996 | 8 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1996 | 8 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 144 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 2550 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1996 | 93 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1997 | 237 | 0.030 |
Why?
|
| Species Specificity | 1 | 1997 | 303 | 0.030 |
Why?
|
| Clone Cells | 1 | 1996 | 67 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 214 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2008 | 2791 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 376 | 0.030 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Aquaculture | 1 | 2014 | 4 | 0.030 |
Why?
|
| Egg Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 95 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 52 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2014 | 13 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 44 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 165 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 1994 | 84 | 0.030 |
Why?
|
| Seawater | 1 | 2014 | 29 | 0.030 |
Why?
|
| Ammonia | 1 | 2014 | 28 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2014 | 108 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 57 | 0.030 |
Why?
|
| Thyroxine | 1 | 2014 | 62 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 37 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 127 | 0.030 |
Why?
|
| Trypsin | 1 | 2013 | 64 | 0.030 |
Why?
|
| Epidermis | 1 | 2013 | 42 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 248 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 124 | 0.030 |
Why?
|
| Urbanization | 1 | 2012 | 4 | 0.030 |
Why?
|
| Los Angeles | 1 | 2012 | 30 | 0.030 |
Why?
|
| Gonads | 1 | 2012 | 8 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 191 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 176 | 0.030 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 12 | 0.030 |
Why?
|
| Proteolysis | 1 | 2013 | 97 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 108 | 0.030 |
Why?
|
| Growth Differentiation Factor 9 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Receptors, LH | 1 | 2012 | 4 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 4 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 434 | 0.030 |
Why?
|
| Artemia | 1 | 2011 | 1 | 0.030 |
Why?
|
| Rotifera | 1 | 2011 | 1 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 15 | 0.030 |
Why?
|
| TATA Box | 1 | 2011 | 7 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 57 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 14 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.030 |
Why?
|
| Netrins | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 525 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 63 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 13 | 0.020 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2011 | 1 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2011 | 15 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 12 | 0.020 |
Why?
|
| Metallothionein | 1 | 2011 | 20 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 173 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2011 | 22 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 100 | 0.020 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2011 | 18 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 10 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 88 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 196 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 126 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 64 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 132 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 32 | 0.020 |
Why?
|
| Protein Binding | 2 | 2009 | 1027 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1033 | 0.020 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Muscles | 1 | 2011 | 158 | 0.020 |
Why?
|
| Histones | 1 | 2011 | 111 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 226 | 0.020 |
Why?
|
| Fetus | 1 | 2011 | 157 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 191 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 65 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 254 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1200 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 500 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.020 |
Why?
|
| Genome, Protozoan | 1 | 2010 | 8 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 146 | 0.020 |
Why?
|
| Pancreas | 1 | 2011 | 225 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 23 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 489 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2010 | 137 | 0.020 |
Why?
|
| Apgar Score | 1 | 2009 | 22 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2009 | 5 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2009 | 8 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2009 | 39 | 0.020 |
Why?
|
| Monosomy | 1 | 2009 | 6 | 0.020 |
Why?
|
| Lung | 2 | 2008 | 849 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 954 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2008 | 10 | 0.020 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2009 | 37 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 33 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 71 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2008 | 18 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2009 | 101 | 0.020 |
Why?
|
| Cockroaches | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 66 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2009 | 238 | 0.020 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 1 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 630 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 28 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 40 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 69 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2009 | 114 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Allergens | 1 | 2008 | 54 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 92 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2008 | 50 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 77 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 69 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2008 | 52 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2008 | 81 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 389 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 627 | 0.020 |
Why?
|
| Leukocytes | 1 | 2008 | 99 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1174 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2009 | 223 | 0.020 |
Why?
|
| Immunity | 1 | 2008 | 67 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2011 | 342 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 134 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 81 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 230 | 0.020 |
Why?
|
| Bilirubin | 1 | 2008 | 51 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 2 | 1998 | 6 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 239 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 280 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 217 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 852 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 330 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 791 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 266 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2007 | 371 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 596 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 411 | 0.020 |
Why?
|
| Antioxidants | 1 | 2008 | 304 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2008 | 279 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 499 | 0.020 |
Why?
|
| Length of Stay | 1 | 2009 | 780 | 0.020 |
Why?
|
| Self Administration | 1 | 2007 | 419 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 649 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 2007 | 241 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2008 | 384 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1864 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 981 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2455 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3705 | 0.010 |
Why?
|
| Mutagens | 1 | 1999 | 18 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 60 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1999 | 161 | 0.010 |
Why?
|
| Toll-Like Receptor 5 | 1 | 1998 | 4 | 0.010 |
Why?
|
| Temperature | 1 | 1999 | 341 | 0.010 |
Why?
|
| Testis | 1 | 1998 | 37 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1998 | 56 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 396 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 1196 | 0.010 |
Why?
|
| Kidney | 1 | 1998 | 945 | 0.010 |
Why?
|
| Myocardium | 1 | 1998 | 1204 | 0.010 |
Why?
|